Paradoxically, Cu2+ chelation using disulfiram (DSF) suppresses FDX1-mediated cuproptosis pathways, attenuating NF-κB activation and preserving BBB integrity during cerebral ischemia (87). The gene discussed is FDX1; the disease is Cerebral ischemia.